help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Solomon, A.
Right arrow Articles by Pepys, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Solomon, A.
Right arrow Articles by Pepys, M. B.

American Journal of Pathology, Vol 140, 629-637, Copyright © 1992 by American Society for Investigative Pathology


REGULAR ARTICLES

Induction in mice of human light-chain-associated amyloidosis

A Solomon, DT Weiss and MB Pepys
Department of Medicine, University of Tennessee Medical Center/Graduate School of Medicine, Knoxville 37920.

Primary (idiopathic) or multiple myeloma-associated amyloidosis is characterized by the deposition in tissue of monoclonal light chains or light-chain fragments (AL amyloidosis). In contrast to other types of amyloidosis, information regarding the pathogenesis of light-chain- related amyloid has heretofore been limited due to the lack of a suitable in vivo model. The authors report the successful experimental induction of human AL amyloid deposits. The repeated injection into mice of Bence Jones proteins obtained from two patients with AL amyloidosis produced the histopathologic lesions characteristic of this disease. Partial dehydration of animals before protein injection resulted in the acceleration of amyloid formation. The human proteins were deposited as amyloid within the mouse renal blood vessel walls and parenchymal tissue, as well as in other organs. The deposits were Congo red-positive, exhibited green birefringence, and had a fibrillar ultrastructure. As evidenced immunohistochemically, the experimentally induced amyloid deposits consisted of the injected human light chains, and in addition, contained mouse amyloid P component (AP); mouse immunoglobulin (Ig) or inflammatory-associated amyloid A protein was not detected. Extraction and characterization of the amyloid deposits found within the mouse kidney revealed the presence of a predominantly intact human light polypeptide chain. Mice injected in identical manner with a non-amyloid-associated Bence Jones protein had no or only rare amyloid deposits. The experimental mouse model provides a means to ascertain the amyloidogenic potential of human monoclonal light chains and to study further the pathogenesis of AL amyloidosis.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Solomon, D. T. Weiss, C. L. Murphy, R. Hrncic, J. S. Wall, and M. Schell
Light chain-associated amyloid deposits comprised of a novel kappa  constant domain
PNAS, August 4, 1998; 95(16): 9547 - 9551.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. Solomon and D. T. Weiss
Ominous Consequences of Immunoglobulin Deposition
N. Engl. J. Med., November 4, 1993; 329(19): 1422 - 1423.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Society for Investigative Pathology.